Automation and Know-How Vital for Cell and Gene Therapy Scaleup
Cell and gene therapy (CGT) manufacturers can struggle to move from lab-scale to clinical-scale production. Automation can help but, to make a success of the transition, developers must be willing to learn from other industries. So says Josh Ludwig, global director of...
EveryLife Statement on the Creation of FDA Rare Disease Innovation Hub
The EveryLife Foundation for Rare Diseases commends the Food and Drug Administration (FDA) on today's announcement of its intention to create a Rare Disease Innovation Hub. Co-chaired by CDER Director, Dr. Peter Marks, and CBER Director, Dr. Patrizia Cavazzoni, the...
OANDA Prop Trader Enables Crypto Payments and Launches $10,000 Giveaway Sweepstakes
OANDA Prop Trader enables crypto payments, giving customers the option to pay for Challenges using cryptocurrencies, and launches $10,000 Giveaway Sweepstakes OANDA announced today that it has introduced cryptocurrencies* as a payment method in its prop trading...
CordenPharma injects €900M to boost GLP-1 manufacturing in US and Europe
In its biggest investment so far, CordenPharma is earmarking €900 million ($982 million) over the next three years to expand its peptide platform capacity in the US and Europe to meet rising GLP-1 manufacturing demand. The Swiss CDMO has “played a pretty significant...
Univercells Technologies and UPENN Expand Gene Therapy Partnership
Univercells Technologies, acquired in June 2023 by Donaldson, says that the Gene Therapy Program at the University of Pennsylvania (GTP) is expanding its evaluation agreement aimed at determining the scalability of GTP’s gene therapy product manufacturing using...
Rznomics Inc. Secures Australian Clinical Trial Notification for RHO-targeted Splicing Ribozyme-based RNA Editing Therapy for Retinitis Pigmentosa
Rznomics Inc., a South Korea based biopharmaceutical company specialized in the development of RNA-based gene therapeutics, announced that it has received Clinical Trial Notification (CTN) from the Australian Therapeutic Goods Administration (TGA) for the initiation...
Nona Biosciences Enters into Collaboration Agreement with Alaya.bio to Advance CAR-T Cell Therapy
Nona Biosciences, a global biotechnology company providing a total solution from "Idea to IND" (I to ITM), ranging from target validation and antibody discovery through preclinical research, announced today that it has entered into a collaboration agreement with...
Flagship Pioneering Raises $3.6B, Plans 25 New Startups
Venture capital giant Flagship Pioneering plans to support the creation and development of about 25 new startups in life sciences or “human health,” sustainability, and artificial intelligence over the next three to five years with a combined $3.6 billion in new...
Senate Passes Bipartisan Bill to Lower Drug Prices and Combat Patent Abuses
WASHINGTON, D.C. – In a significant bipartisan effort to address skyrocketing drug prices, the U.S. Senate has unanimously passed the Affordable Prescriptions for Patients Act. The bill, introduced by Senators John Cornyn (R-TX) and Richard Blumenthal (D-CT), aims to...
UniQure’s New Gene Therapy Shows Promise in Slowing Huntington’s Disease Progression
UniQure has announced encouraging interim results from its Phase 1/2 trials of AMT-130, a gene therapy for Huntington's disease. The trials, conducted in the U.S. and Europe, followed 21 patients over 24 months, with the data indicating a significant slowing of...
Sirnaomics Announces Completion of IND-Enabling Studies of Safety and Efficacy for STP125G with NHP Models, Targeting ApoC3 for Treatment of Cardiovascular Diseases
Sirnaomics Ltd. (the "Company", Stock Code: 2257.HK, together with its subsidiaries, the "Group" or "Sirnaomics"), a leading biopharmaceutical company engaging in discovery and development of advanced RNAi therapeutics, announced today that the Group has completed...
Moderna and Mitsubishi Tanabe Pharma Partner on mRNA Respiratory Vaccines in Japan
On July 8th, Moderna, Inc. and Mitsubishi Tanabe Pharma Corporation (MTPC) officially entered into a joint agreement to co-promote Moderna’s mRNA respiratory vaccine portfolio in Japan, alongside Moderna’s COVID-19 vaccine, Spikevax. Moderna’s Success Sparks...
Popular Services
AAV Packaging Service
AAV Analytical Service
Vector Design